Fri Dec 13 04:46:20 UTC 2024: **Strong Investor Interest in MobiKwik, Vishal Mega Mart, and Sai Life Sciences IPOs**

**MUMBAI, Dec 12, 2024** – Three initial public offerings (IPOs) – MobiKwik, Vishal Mega Mart, and Sai Life Sciences – saw robust investor demand on their second day of bidding. MobiKwik led the pack, with its issue oversubscribed 20.41 times, driven by strong interest from retail and non-institutional investors. The company, boasting a 24% market share in the PPI wallet segment, is valued at 2.3x EV/Sales, a figure analysts at Nirmal Bang deem attractive, recommending a “Subscribe” rating based on profitability and strong brand presence.

Vishal Mega Mart’s IPO was oversubscribed 1.54 times overall, with NIIs and retail investors showing 3.84 times and 1.16 times subscription, respectively. Lemonn Markets sees the IPO as attractively priced at 76x FY24 PE, citing a robust 50% CAGR growth in EPS and recommending a long-term hold for retail investors focused on the sector.

Sai Life Sciences’ IPO achieved a 1.25 times subscription, buoyed by qualified institutional buyers (QIBs). While valued at 39.5x EV/EBITDA, Nirmal Bang analysts point out this represents a discount compared to industry averages, suggesting a “SUBSCRIBE” rating with a long-term perspective, despite currently lower operating margins than competitors. The firm anticipates improved profitability following a significant debt reduction.

All three IPOs are scheduled to close on Friday, December 13th.

Read More